Nanosyrinx

Developer of targeted intracellular delivery platform for biological molecules

placeCoventry, England, United Kingdom calendar_todayFounded 2018 groups3 employees language nanosyrinx.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 3 times.

YearFilings
20221
20253

Social engagement

Social engagement: 2.8K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include M Ventures, Octopus Ventures, BGF.

Investor typeCountShare
Venture capital741%
Accelerator & incubator318%
Other / undisclosed741%

Recent activity

8 Jan 2026
Leadership hire
CEO
14 Oct 2025
Event
ESMO - European Society for Medical Oncology
Coming soon